Literature DB >> 18632297

Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.

J-L Richard1, A Sotto, N Jourdan, C Combescure, D Vannereau, M Rodier, J-P Lavigne.   

Abstract

AIM: To determine the risk factors for acquiring multidrug-resistant organisms (MDRO) and their impact on outcome in infected diabetic foot ulcers.
METHODS: Patients hospitalized in our diabetic foot unit for an episode of infected foot ulcer were prospectively included. Diagnosis of infection was based on clinical findings using the International Working Group on the Diabetic Foot-Infectious Diseases Society of America (IWGDF-ISDA) system, and wound specimens were obtained for bacterial cultures. Each patient was followed-up for 1 year. Univariate analysis was performed to compare infected ulcers according to the presence or absence of MDRO; logistic regression was used to identify explanatory variables for MDRO presence. Factors related to healing time were evaluated by univariate and multivariate survival analyses.
RESULTS: MDRO were isolated in 45 (23.9%) of the 188 patients studied. Deep and recurrent ulcer, previous hospitalization, HbA(1c) level, nephropathy and retinopathy were significantly associated with MDRO-infected ulceration. By multivariate analysis, previous hospitalization (OR=99.6, 95% CI=[19.9-499.0]) and proliferative retinopathy (OR=7.4, 95% CI=[1.6-33.7]) significantly increased the risk of MDRO infection. Superficial ulcers were associated with a significant decrease in healing time, whereas neuroischaemic ulcer, proliferative retinopathy and high HbA(1c) level were associated with an increased healing time. In the multivariate analysis, presence of MDRO had no significant influence on healing time.
CONCLUSION: MDRO are pathogens frequently isolated from diabetic foot infection in our foot clinic. Nevertheless, their presence appears to have no significant impact on healing time if early aggressive treatment, as in the present study, is given, including empirical broad-spectrum antibiotic treatment, later adjusted according to microbiological findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632297     DOI: 10.1016/j.diabet.2008.02.005

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  24 in total

Review 1.  Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.

Authors:  Andreas Ambrosch; Simone Haefner; Edward Jude; Ralf Lobmann
Journal:  Int Wound J       Date:  2011-08-23       Impact factor: 3.315

Review 2.  The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey.

Authors:  M Hatipoglu; M Mutluoglu; G Uzun; E Karabacak; V Turhan; B A Lipsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

3.  Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers.

Authors:  A Sotto; J-L Richard; C Combescure; N Jourdan; S Schuldiner; N Bouziges; J-P Lavigne
Journal:  Diabetologia       Date:  2010-06-23       Impact factor: 10.122

Review 4.  Methicillin-resistant Staphylococcus aureus in diabetic foot infections.

Authors:  Ioanna Eleftheriadou; Nicholas Tentolouris; Vasiliki Argiana; Edward Jude; Andrew J Boulton
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

5.  New insights in diabetic foot infection.

Authors:  Jean-Louis Richard; Albert Sotto; Jean-Philippe Lavigne
Journal:  World J Diabetes       Date:  2011-02-15

6.  A prospective, multi-center study: factors related to the management of diabetic foot infections.

Authors:  B M Ertugrul; O Oncul; N Tulek; A Willke; S Sacar; O G Tunccan; E Yilmaz; O Kaya; B Ozturk; O Turhan; N Yapar; M Ture; F Akin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-22       Impact factor: 3.267

7.  Management of diabetic foot infections in an era of increasing microbial resistance.

Authors:  Sandra Bliss Nelson
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

8.  High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study).

Authors:  Robert J Commons; Claire H Robinson; David Gawler; Joshua S Davis; Ric N Price
Journal:  Diabetes Res Clin Pract       Date:  2015-09-21       Impact factor: 5.602

9.  Bacteriological profile and antibiotic susceptibility of diabetic Foot infections at Ribat University hospital; a retrospective study from Sudan.

Authors:  Maram H Hamid; Ahmed H Arbab; Bashir A Yousef
Journal:  J Diabetes Metab Disord       Date:  2020-10-13

Review 10.  The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review.

Authors:  Gianmarco Matta-Gutiérrez; Esther García-Morales; Yolanda García-Álvarez; Francisco Javier Álvaro-Afonso; Raúl Juan Molines-Barroso; José Luis Lázaro-Martínez
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.